<p>Survival curves represent the cumulative percentage of uninfected macaques as a function of the number of months in the study period (4 challenges per month). Control macaques become infected after a median of 3.5 exposures or about 1 menstrual cycle. Virus challenges in the macaques receiving Truvada were stopped after 18 SHIV<sub>SF162P3</sub> exposures or about 4.5 menstrual cycles. Protected animals remained seronegative and RNA/DNA negative during a follow up period of 18 weeks.</p
In the absence of an effective vaccine, HIV continues to spread globally, emphasizing the need for n...
<p><b>TDF-FTC pod-IVR efficacy in macaques</b> (A) Kaplan-Meier plot showing complete protection for...
<p>SHIV-specific T cells were measured during the indicated experimental procedures. Arrows indicate...
Daily pre-exposure prophylaxis (PrEP) with Truvada (a combination of emtricitabine (FTC) and tenofov...
<p>Viral loads in placebo (<b>A</b>) and M48U1-gel (<b>B</b>) treated macaques. One hour after gel a...
<p>Beginning at week 0, rhesus macaques were challenged once weekly with 4 TCID<sub>50</sub> (A, B) ...
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
Maraviroc (MVC) gels are effective at protecting rhesus macaques from vaginal SHIV transmission, but...
<p>Animals remained protected from infection for an average of 4 complete menstrual cycles as indica...
<p>SHIV RNA levels in plasma (red circles), vaginal secretions (open circle), and rectal secretions ...
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
<p>Beginning at week 0, rhesus macaques were challenged twice weekly with 200 TCID<sub>50</sub> (A, ...
Maraviroc (MVC) gels are effective at protecting rhesus macaques from vaginal SHIV transmission, but...
Maraviroc (MVC) gels are effective at protecting rhesus macaques from vaginal SHIV transmission, but...
<p>A total of nine female Indian rhesus macaques were divided into treatment groups of five animals ...
In the absence of an effective vaccine, HIV continues to spread globally, emphasizing the need for n...
<p><b>TDF-FTC pod-IVR efficacy in macaques</b> (A) Kaplan-Meier plot showing complete protection for...
<p>SHIV-specific T cells were measured during the indicated experimental procedures. Arrows indicate...
Daily pre-exposure prophylaxis (PrEP) with Truvada (a combination of emtricitabine (FTC) and tenofov...
<p>Viral loads in placebo (<b>A</b>) and M48U1-gel (<b>B</b>) treated macaques. One hour after gel a...
<p>Beginning at week 0, rhesus macaques were challenged once weekly with 4 TCID<sub>50</sub> (A, B) ...
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
Maraviroc (MVC) gels are effective at protecting rhesus macaques from vaginal SHIV transmission, but...
<p>Animals remained protected from infection for an average of 4 complete menstrual cycles as indica...
<p>SHIV RNA levels in plasma (red circles), vaginal secretions (open circle), and rectal secretions ...
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
<p>Beginning at week 0, rhesus macaques were challenged twice weekly with 200 TCID<sub>50</sub> (A, ...
Maraviroc (MVC) gels are effective at protecting rhesus macaques from vaginal SHIV transmission, but...
Maraviroc (MVC) gels are effective at protecting rhesus macaques from vaginal SHIV transmission, but...
<p>A total of nine female Indian rhesus macaques were divided into treatment groups of five animals ...
In the absence of an effective vaccine, HIV continues to spread globally, emphasizing the need for n...
<p><b>TDF-FTC pod-IVR efficacy in macaques</b> (A) Kaplan-Meier plot showing complete protection for...
<p>SHIV-specific T cells were measured during the indicated experimental procedures. Arrows indicate...